Unknown

Dataset Information

Tumor promoting effects of CD95 signaling in chemoresistant cells.


ABSTRACT:

Background

CD95 is a death receptor controlling not only apoptotic pathways but also activating mechanisms promoting tumor growth. During the acquisition of chemoresistance to oxaliplatin there is a progressive loss of CD95 expression in colon cancer cells and a decreased ability of this receptor to induce cell death. The aim of this study was to characterize some key cellular responses controlled by CD95 signaling in oxaliplatin-resistant colon cancer cells.

Results

We show that CD95 triggering results in an increased metastatic ability in resistant cells. Moreover, oxaliplatin treatment itself stimulates cell migration and decreases cell adhesion through CD95 activation, since CD95 expression inhibition by siRNA blocks the promigratory effects of oxaliplatin. These promigr

SUBMITTER: Ametller E 

PROVIDER: S-EPMC2906471 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature